Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Beiersdorf AG buy Mori8

Start price
€103.35
21.06.21 / 80%
Target price
-
21.06.22
Performance (%)
-3.05%
End price
€100.20
22.07.21
Summary
This prediction ended on 22.07.21 with a price of €100.20. With a performance of -3.05%, the BUY prediction for Beiersdorf AG by Mori8 closed slightly in the red. Mori8 has 80% into this prediction

Beiersdorf is a multinational skincare company based in Hamburg, Germany. The company was founded in 1882 and is best known for its Nivea brand of skin and beauty products. Beiersdorf operates in over 170 countries and employs over 20,000 people worldwide. In addition to Nivea, the company also owns other brands such as Eucerin, La Prairie and Hansaplast. Beiersdorf is listed on the Frankfurt and Hamburg stock exchanges and has a market capitalization of over €24 billion as of 2021.

Performance without dividends (%)
Name 1w 1m 1y
Beiersdorf AG 1.875% 1.875% 14.981%
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to Mori8 what are the pros and cons of Beiersdorf AG for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Fair valuation
positive Cash Flow expected
High Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Cons

Comments by Mori8 for this prediction

In the thread Beiersdorf AG diskutieren

Buy Beiersdorf AG

https://www.pharma-food.de/markt/beiersdorf-plant-lieferketten-drehkreuz-bei-leipzig-122.html

JEFFERIES belässt BEIERSDORF AG auf 'Buy'

NEW YORK (dpa-AFX Analyser) - Die Investmentbank Jefferies hat die Einstufung für Beiersdorf auf "Buy" mit einem Kursziel von 120 Euro belassen. Er gehe im Lebensmittel- und Konsumgütersektor etwas vorsichtiger als der Konsens an das zweite Quartal heran, schrieb Analyst Martin Deboo in einer am Mittwoch vorliegenden Studie. Das größte Risiko in Zeiten anspruchsvollerer Aktienbewertungen sieht er derzeit in den steigenden Rohstoffpreisen. Außerdem dürfte bei vielen Unternehmen erst spät klar werden, ob die Geschäftsziele erreicht würden

ANALYSE-FLASH: Stifel nimmt Beiersdorf mit 'Buy' wieder auf - Ziel 115 Euro

FRANKFURT (dpa-AFX) - Stifel hat die Bewertung der Papiere von Beiersdorf bei einem Kursziel von 115 Euro mit "Buy" wieder aufgenommen. Analyst Rogerio Fujimori lobte die starke Umsatzdynamik der Hamburger in einer am Freitag vorliegenden Studie. Das Verhältnis zwischen Chancen und Risiken erscheine attraktiv./ag/mis


In the thread Trading Beiersdorf AG
Prediction Buy
Perf. (%) -3.05%
Target price
Change
Ends at 21.06.22

Buy beendet

Stopped prediction by Mori8 for Beiersdorf AG

buy
Beiersdorf AG

Start price
Target price
Perf. (%)
€100.20
22.07.21
-
22.07.22
6.04%
13.08.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Beiersdorf AG

Start price
Target price
Perf. (%)
€90.60
22.01.21
-
22.01.22
14.07%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Beiersdorf AG

Start price
Target price
Perf. (%)
€98.98
24.06.20
€100.00
04.11.21
-8.55%
22.01.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Beiersdorf AG

Start price
Target price
Perf. (%)
€86.12
24.01.19
€108.88
12.06.19
25.23%
12.06.19

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Beiersdorf AG

Start price
Target price
Perf. (%)
€87.78
13.03.18
€110.00
18.04.18
6.17%
18.04.18

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Fair valuation